Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the… read more →
We illustrate application of our one-stop metabolite shop in meeting metabolite requirements for various client projects using different techniques in… read more →
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response… read more →
Some metabolites are not easy to access. Even if sufficient material can be isolated from biological matrices for definitive metID,… read more →
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the… read more →
Our latest PolyCYPs bulletin features a case study in which one of our US pharma clients needed rapid access to… read more →
We are excited to announce the official launch of our One-Stop Metabolite Shop, which offers a complete solution for pharma… read more →
Hypha’s PolyCYPs enzymes have been routinely used by pharma and agchem companies for producing metabolites. One application involves direct comparison… read more →
Hypha are looking forward to presenting two posters at the ISSX meeting held in Portland US from 28th to 31st… read more →
Our newsletter this quarter looks at the use of microbial biotransformation to synthesize glucuronide metabolites, with a particular emphasis on… read more →